BLACKPRESSUSA NEWSWIRE — Across the United States, the demand for these drugs has surged. A 2024 Gallup survey found that 6% of U.S. adults—about 15.5 million...
NNPA NEWSWIRE — "This is a moment in time for Americans to move past our divisions to come together and reach our full potential as a...
NNPA NEWSWIRE — The difficulty in producing a vaccine for the deadly virus comes as a new wave of COVID-19 infection has begun. Data provided by...
NNPA NEWSWIRE — "We constantly have to innovate, and we cannot rest on last year's medical advances," stated Nathaniel Miles, the vice president for strategic initiatives...
NNPA NEWSWIRE — An annual highlight of the conference was the 2020 NNPA Publisher Lifetime Achievement Award, which was presented to The Dallas Examiner’s distinguished publisher,...
NNPA NEWSWIRE — The 2019 honorees are the Honorable Karen Bass, U.S. Representative (D-CA); the Honorable Elijah E. Cummings, U.S. Representative (D-MD); the Honorable Bobby Scott,...
NNPA NEWSWIRE — The 2019 honorees are the Honorable Karen Bass, U.S. Representative (D-CA); the Honorable Elijah E. Cummings, U.S. Representative (D-MD); the Honorable Bobby Scott,...
NNPA NEWSWIRE — Not only does the African American community face the dilemma of increased diabetes diagnoses, but also faces numerous health care challenges when trying...
WASHINGTON (AP) — The Food and Drug Administration has approved a new injectable diabetes drug from Eli Lilly and Co. for adults with the...
YURI KAGEYAMA, AP Business Writer TOKYO (AP) — A U.S. jury ordered Japanese drugmaker Takeda Pharmaceutical Co. and its U.S. counterpart, Eli Lilly and Co., to...
Feb 25 (Reuters) – An experimental once-weekly medicine for type 2 diabetes developed by Eli Lilly and Co proved as effective in lowering blood sugar as...
[Business Week] The long promise of insulin that diabetics can inhale appears to be moving closer to the market. An inhalable insulin powder called Afrezza showed...
